HRT Financial
DOVA

HRT Financial’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

HRT Financial’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,175
Closed -$228K – 1896
2019
Q3 		$228K Buy
+8,175
New +$132K 0.01% 1084

HRT Financial's DOVA Position: Q4 2019 in Review

HRT Financial sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 8,175 shares — an estimated $228K sold.

HRT Financial first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $228K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • HRT Financial reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • HRT Financial sold 8,175 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $228K.
  • HRT Financial first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • HRT Financial's Dova Pharmaceuticals, Inc. Common Stock position peaked at $228K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on HRT Financial's 13F filing for Q4 2019, filed 14 Feb 2020.